Latest Channelopathy Stories
Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development Philadelphia (PRWEB) April 10, 2014 ERT, a leading
A rare and potentially lethal disease of newborn babies whose bodies make too much insulin may be treatable with fish oils.
BOULDER, Colo., March 12, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc. ("N30 Pharma") announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial.
New research report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth” worked out by GBI Research
Katrine Whiteson and colleagues identified a lung-damaging molecule in higher concentrations in cystic fibrosis patients during symptom flare-ups.
ResearchMoz.us include new market research report "Cystic Fibrosis Therapeutics in Major Developed Markets to 2019" to its huge collection of research reports.
Grant to Fulfill Wishes for Children Living with Cystic Fibrosis Narberth, PA (PRWEB) January 14, 2014 The Take a Breather Foundation is proud to announce
19th Annual “The Eyes of Christmas™ ” Television Special for the Visually Impaired Kicks-off with “It’s A Wonderful Life,” Audio Described by former US President George H.W.
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.